The Investigator-Initiated Research Award, offered through the U.S. Department of Defense Congressionally Directed Medical Research Programs (CDMRP) under the FY26 Ovarian Cancer Research Program (OCRP), supports innovative, high-impact research with clear clinical relevance across the full spectrum of ovarian cancer — including disease biology, prevention, early detection, treatment, and survivorship. The mechanism is designed to advance work with strong translational potential to benefit ovarian cancer patients. The program announcement was released May 4, 2026, and applications are submitted through the electronic Biomedical Research Application Portal (eBRAP).
Eligibility Criteria:
- Open to independent investigators leading the proposed research.
- U.S. and international institutions are generally eligible under CDMRP application instructions.
- Specific career-stage and institutional requirements are detailed in the OCRP Program Announcement; applicants should confirm eligibility before submitting.
Funding Details:
- Award amounts and period of performance are specified in the FY26 OCRP Program Announcement; confirm current figures via eBRAP and the program announcement before applying.
Deadline:
- Pre-application (pre-proposal) due: July 13, 2026 (5:00 p.m. ET).
- Full application due: October 1, 2026 (11:59 p.m. ET).
- Program announcement released: May 4, 2026.
Where to Go for Further Information:
- DoD Ovarian Cancer Research Program.
- Pre-application and full application submitted via eBRAP.